Establishing the Future Direction of Clinical Outcomes in C3 Glomerulopathy: Perspectives From a Patient and a Physician.

Complement 3 glomerulopathy (C3G) is an ultra-rare glomerulonephritis caused by dysregulation of the alternative complement pathway. C3G has an estimated incidence of 1-3 cases per million people in the United States. Diagnosing C3G based solely on clinical and laboratory features is challenging because it mimics several other glomerular diseases; therefore, diagnosis requires a kidney biopsy.

Electrolyte Anions Suppress Hydrogen Generation in Electrochemical CO Reduction on Cu.

In this study, we employed EC-MS to elucidate the role of halide anions in electrochemical CO2 and CO reduction. We found that the undesired hydrogen evolution reaction (HER) was significantly suppressed by the anion used. Specifically, the rates of H2 production decreased in the order KF > KCl > KI, meaning that I- most strongly suppressed HER.

Interfacing CuO, CuBiO, and protective metal oxide layers to boost solar-driven photoelectrochemical hydrogen evolution.

This article reports the development of CuO|CuBiO photocathodes stabilized by protective layers of TiO, MgO, or NiO, with Pt or MoS nanoparticles serving as co-catalysts to facilitate H evolution. Most notably, this work demonstrates the first application of MgO as a protection/passivation layer for photocathodes in a water-splitting cell. All configurations of photocathodes were studied structurally, morphologically, and photoelectrochemically revealing that CuO|CuBiO|MgO|Pt photocathodes achieve the highest stable photocurrent densities of -200 μA cm for over 3 hours with a Faradaic efficiency of ∼90%.

Associations of Obesity with Post-Treatment Risks of Cervical Precancer and Cancer.

Background: Individuals with obesity have an increased risk of cervical cancer, in part related to challenges associated with cervical sampling and visualization that result in missed detection of cervical precancers. The influence of obesity on the effectiveness of excisional treatment of detected cervical precancers and post-treatment disease risk is unknown.

Objectives: The aim of this study was to evaluate post-treatment risks of cervical precancer and cancer by body mass index (BMI).